Richard J. Baron, MD, President and Chief Executive Officer of ABIM & ABIM Foundation
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of July 2020, Dr. Baron reported no financial relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Richard G. Battaglia, MD, Chief Medical Officer
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of June 2020, Dr. Battaglia reported no ongoing financial relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Bradley Brossman, Vice President of Psychometrics
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of June 2020, Dr. Brossman reported no ongoing financial relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Judi Cassel, MPP, Chief of Staff
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of June 2020, Ms. Cassel reported no ongoing financial relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Jeremy Dugosh, Interim Vice President, Ph.D., Test Development
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of July 2020, Dr. Dugosh reported the following ongoing financial relationships with other healthcare-related companies.
Dr. Dugosh serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Thomas Jefferson University Hospital Institutional Review Board, non-affiliated scientist member, without compensation.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Rebecca S. Lipner, Senior Vice President, Assessment and Research
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of July 2020, Dr. Lipner reported the following relationships with other healthcare-related companies.
Dr. Lipner received the John H. Hubbard Award for Medical Evaluation Research from the National Board of Medical Examiners.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Lorna A. Lynn, MD, Vice President, Medical Education Research
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of July 2020, Dr. Lynn reported no ongoing relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Vincent J. Mandes, Chief Financial Officer
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of June 2020, Mr. Mandes reported no ongoing financial relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Furman S. McDonald, MD, MPH, Senior Vice President for Academic and Medical Affairs
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of July 2020, Dr. McDonald reported the following ongoing relationships with other healthcare-related companies:
Work as an editor or author
Work as an author or editor for following companies, with compensation as listed below:
Mayo Clinic Scientific Press, receiving compensation as an author, paid to Mayo International Health Program.
Dr. McDonald also reported that he is an American Board of Internal Medicine Ex-Officio Member of the Accreditation Council for Graduate Medical Education Residency Review Committee for Internal Medicine and also of the Association of Program Directors Survey and Scholarship Committee.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Jeffrey Miller, MSIS, Vice President, Information Technology
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of June 2020, Mr. Miller reported no ongoing financial relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.
Pamela Browner White
ABIM recognizes the potential value of many types of relationships between health care experts and the healthcare-related industry. To help ensure the independence of all ABIM policies, programs and products, ABIM requires that those who serve on ABIM boards and committees provide detailed disclosures about their relationships with healthcare-related companies, including research, educational activities, intellectual property and service on healthcare-related company boards. Leadership roles with and grant funding or other compensation from other non-profit healthcare-related organizations are also disclosed. This information is shared among members of each board or committee, enabling open discussion about the nature of the work involved and any possible influence on the work of ABIM.
As of June 2019, Ms. Browner White reported no ongoing financial relationships with other healthcare-related companies.
ABIM collects—and members share—information in much more detail than is reported here. We welcome questions about our Conflict of Interest (COI) policies and processes. Please contact us at ABIM Governance Services if you have any questions.